Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes. 2000;49(8):1359–66.

Article  CAS  PubMed  Google Scholar 

Hughes AE, De Franco E, Globa E, Zelinska N, Hilgard D, Sifianou P, et al. Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: a case series and review of clinical features. Pediatr Diabetes. 2021;22(6):876–81.

Article  PubMed  PubMed Central  Google Scholar 

Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med. 2006;355(5):467–77.

Article  CAS  PubMed  Google Scholar 

Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2008;31(2):204–9.

Article  CAS  PubMed  Google Scholar 

De Franco E, Flanagan SE, Houghton JA, Lango Allen H, Mackay DJ, Temple IK, et al. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet. 2015;386(9997):957–63.

Article  PubMed  PubMed Central  Google Scholar 

Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, Ellard S, Hattersley AT. Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care. 2015;38(7):1383–92.

Article  CAS  PubMed  Google Scholar 

Gloyn AL. Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy. Hum Mutat. 2003;22(5):353–62.

Article  CAS  PubMed  Google Scholar 

Li X, Ting TH, Sheng H, Liang CL, Shao Y, Jiang M, et al. Genetic and clinical characteristics of Chinese children with glucokinase-maturity-onset diabetes of the young (GCK-MODY). BMC Pediatr. 2018;18(1):101.

Article  PubMed  PubMed Central  Google Scholar 

Udler MS, Powe CE, Austin-Tse CA. Case 6-2020: a 34-year-old woman with hyperglycemia. N Engl J Med. 2020;382(8):745–53.

Article  PubMed  PubMed Central  Google Scholar 

Stride A, Shields B, Gill-Carey O, Chakera AJ, Colclough K, Ellard S, Hattersley AT. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia. Diabetologia. 2014;57(1):54–6.

Article  CAS  PubMed  Google Scholar 

Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S. Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet. 1998;19(3):268–70.

Article  CAS  PubMed  Google Scholar 

Spyer G, Macleod KM, Shepherd M, Ellard S, Hattersley AT. Pregnancy outcome in patients with raised blood glucose due to a heterozygous glucokinase gene mutation. Diabet Med. 2009;26(1):14–8.

Article  CAS  PubMed  Google Scholar 

Njølstad PR, Søvik O, Cuesta-Muñoz A, Bjørkhaug L, Massa O, Barbetti F, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001;344(21):1588–92.

Article  PubMed  Google Scholar 

Aloi C, Salina A, Minuto N, Tallone R, Lugani F, Mascagni A, et al. Glucokinase mutations in pediatric patients with impaired fasting glucose. Acta Diabetol. 2017;54:913–23.

Article  CAS  PubMed  Google Scholar